{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:05Z","timestamp":1787003645337,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gazi University Scientific Research Projects Department","award":["Project ID: 7102"],"award-info":[{"award-number":["Project ID: 7102"]}]},{"name":"Gazi University Scientific Research Projects Department","award":["Project ID: 7102"],"award-info":[{"award-number":["Project ID: 7102"]}]},{"name":"Gazi University Scientific Research Projects Department","award":["Project ID: 7102"],"award-info":[{"award-number":["Project ID: 7102"]}]},{"name":"Gazi University Scientific Research Projects Department","award":["Project ID: 7102"],"award-info":[{"award-number":["Project ID: 7102"]}]},{"name":"Gazi University Scientific Research Projects Department","award":["Project ID: 7102"],"award-info":[{"award-number":["Project ID: 7102"]}]},{"name":"Gazi University Scientific Research Projects Department","award":["Project ID: 7102"],"award-info":[{"award-number":["Project ID: 7102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16125-y","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:13:50Z","timestamp":1759749230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic and prognostic potential of microRNA profiles in endometrioid endometrial cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Ya\u011fmur","family":"Soykan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9201-8464","authenticated-orcid":false,"given":"Atiye Seda","family":"Yar Saglam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Arda","family":"Inan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3204-7562","authenticated-orcid":false,"given":"Asiye","family":"Ugras Dikmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-1585","authenticated-orcid":false,"given":"\u00d6zlem","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet An\u0131l","family":"Onan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"16125_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics 2012. CA Cancer J. Clin. 65, 87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"16125_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin, N. et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int. J. Gynecol. Cancer. 31, 12\u201339. https:\/\/doi.org\/10.1136\/ijgc-2020-002230 (2021).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"16125_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by micrornas: are the answers in sight? Nat. Rev. Genet. 9, 102\u2013114. https:\/\/doi.org\/10.1038\/nrg2290 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"16125_CR4","doi-asserted-by":"publisher","unstructured":"Gao, M., Yin, H. & Fei, Z. W. Clinical application of MicroRNA in gastric cancer in Eastern Asian area. World J. Gastroenterol. 19, 2019\u20132027.  https:\/\/doi.org\/10.3748\/wjg.v19.i13.2019 (2013).","DOI":"10.3748\/wjg.v19.i13.2019"},{"key":"16125_CR5","first-page":"2500","volume":"58","author":"GL Maxwell","year":"1998","unstructured":"Maxwell, G. L. et al. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res. 58, 2500\u20132503 (1998).","journal-title":"Cancer Res."},{"key":"16125_CR6","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/1097-0142(20001015)89:8<1758::AID-CNCR16>3.0.CO;2-A","volume":"89","author":"JB Basil","year":"2000","unstructured":"Basil, J. B., Goodfellow, P. J., Rader, J. S., Mutch, D. G. & Herzog, T. J. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer 89, 1758\u20131764 (2000).","journal-title":"Cancer"},{"key":"16125_CR7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","volume":"88","author":"SF Lax","year":"2000","unstructured":"Lax, S. F., Kendall, B., Tashiro, H., Slebos, R. J. & Hedrick, L. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer 88, 814\u2013824 (2000).","journal-title":"Cancer"},{"key":"16125_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/agg.s28953","volume":"2012","author":"AJ O\u2019Hara","year":"2012","unstructured":"O\u2019Hara, A. J. & Bell, D. W. The genomics and genetics of endometrial cancer. J. Adv. Genomics Genet. 2012, 33\u201347. https:\/\/doi.org\/10.2147\/agg.s28953 (2012).","journal-title":"J. Adv. Genomics Genet."},{"issue":"18","key":"16125_CR9","first-page":"3935","volume":"57","author":"H Tashiro","year":"1997","unstructured":"Tashiro, H. et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57(18), 3935\u20133940 (1997).","journal-title":"Cancer Res."},{"issue":"4","key":"16125_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0002-9440(10)65227-3","volume":"155","author":"A Perren","year":"1999","unstructured":"Perren, A. et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am. J. Pathol. 155(4), 1253\u20131260. https:\/\/doi.org\/10.1016\/S0002-9440(10)65227-3 (1999).","journal-title":"Am. J. Pathol."},{"key":"16125_CR11","doi-asserted-by":"publisher","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods 25(4), 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","DOI":"10.1006\/meth.2001.1262"},{"issue":"9","key":"16125_CR12","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"MW Pfaffl","year":"2002","unstructured":"Pfaffl, M. W., Horgan, G. W. & Dempfe, L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30(9), e36. https:\/\/doi.org\/10.1093\/nar\/30.9.e36 (2002).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"16125_CR13","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3892\/mmr.2013.1403","volume":"7","author":"Y Chen","year":"2013","unstructured":"Chen, Y. et al. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated pten\/akt signaling. Mol. Med. Rep. 7(5), 1579\u20131584. https:\/\/doi.org\/10.3892\/mmr.2013.1403 (2013).","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"16125_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/modpathol.2012.111","volume":"25","author":"H Lee","year":"2012","unstructured":"Lee, H., Choi, H. J., Kang, C. S., Lee, H. J., Park, W. S. & CS Expression of MiRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. Mod. Pathol. 25(11), 1508\u20131515. https:\/\/doi.org\/10.1038\/modpathol.2012.111 (2012).","journal-title":"Mod. Pathol."},{"issue":"3","key":"16125_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ygyno.2013.06.026","volume":"130","author":"A Torres","year":"2013","unstructured":"Torres, A., Torres, K., Wdowiak, P., Paszkowski, T. & Maciejewski, R. Selection and validation of endogenous controls for MicroRNA expression studies in endometrioid endometrial cancer tissues. Gynecol. Oncol. 130(3), 588\u2013594. https:\/\/doi.org\/10.1016\/j.ygyno.2013.06.026 (2013).","journal-title":"Gynecol. Oncol."},{"key":"16125_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ygyno.2014.01.029","volume":"132","author":"O Tsukamoto","year":"2014","unstructured":"Tsukamoto, O. et al. Identification of endometrioid endometrial carcinoma-associated MicroRNAs in tissue and plasma. Gynecol. Oncol. 132, 715\u2013721. https:\/\/doi.org\/10.1016\/j.ygyno.2014.01.029 (2014).","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"16125_CR17","doi-asserted-by":"publisher","first-page":"e35158","DOI":"10.1371\/journal.pone.0035158","volume":"7","author":"M Karaayvaz","year":"2012","unstructured":"Karaayvaz, M., Zhang, C., Liang, S., Shroyer, K. R. & Ju, J. Prognostic significance of miR-205 in endometrial cancer. PLoS One. 7(4), e35158. https:\/\/doi.org\/10.1371\/journal.pone.0035158 (2012).","journal-title":"PLoS One"},{"issue":"6","key":"16125_CR18","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3892\/ol.2012.896","volume":"4","author":"X Qin","year":"2012","unstructured":"Qin, X., Yan, L., Zhao, X., Li, C. & Fu, Y. microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol. Lett. 4(6), 1290\u20131296. https:\/\/doi.org\/10.3892\/ol.2012.896 (2012).","journal-title":"Oncol. Lett."},{"key":"16125_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.gene.2018.02.051","volume":"655","author":"NS Geletina","year":"2018","unstructured":"Geletina, N. S. et al. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients. Gene 655, 20\u201324. https:\/\/doi.org\/10.1016\/j.gene.2018.02.051 (2018).","journal-title":"Gene"},{"issue":"9","key":"16125_CR20","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/mc.22839","volume":"57","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. MiR-181a\/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1. Mol. Carcinog. 57(9), 1237\u20131250. https:\/\/doi.org\/10.1002\/mc.22839 (2018).","journal-title":"Mol. Carcinog."},{"key":"16125_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-13-86","volume":"13","author":"D Ji","year":"2014","unstructured":"Ji, D. et al. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol. Cancer. 13, 86. https:\/\/doi.org\/10.1186\/1476-4598-13-86 (2014).","journal-title":"Mol. Cancer"},{"key":"16125_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.abb.2016.06.001","volume":"604","author":"P Hai Ping","year":"2016","unstructured":"Hai Ping, P., Feng Bo, T., Li, L., Nan Hui, Y. & Hong, Z. IL-1\u03b2\/NF-kb signaling promotes colorectal cancer cell growth through miR-181a\/PTEN axis. Archieves Biochem. Biophys. 604, 20\u201326. https:\/\/doi.org\/10.1016\/j.abb.2016.06.001 (2016).","journal-title":"Archieves Biochem. Biophys."},{"issue":"4","key":"16125_CR23","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3892\/or.2013.2267","volume":"29","author":"N Cong","year":"2013","unstructured":"Cong, N. et al. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt\/\u03b2-catenin pathway by targeting the E-cadherin repressors ZEB1\/ZEB2 in gastric adenocarcinoma. Oncol. Repots. 29(4), 1579\u20131587. https:\/\/doi.org\/10.3892\/or.2013.2267 (2013).","journal-title":"Oncol. Repots"},{"issue":"4","key":"16125_CR24","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3892\/ijo.2011.1322","volume":"40","author":"J Su","year":"2012","unstructured":"Su, J. et al. MicroRNA-200a suppresses the Wnt\/\u03b2-catenin signaling pathway by interacting with \u03b2-catenin. Int. J. Oncol. 40(4), 1162\u20131170. https:\/\/doi.org\/10.3892\/ijo.2011.1322 (2012).","journal-title":"Int. J. Oncol."},{"issue":"11","key":"16125_CR25","doi-asserted-by":"publisher","first-page":"e79409","DOI":"10.1371\/journal.pone.0079409","volume":"8","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the \u03b2-catenin pathway in hepatic oval cells. PLoS One. 8(11), e79409. https:\/\/doi.org\/10.1371\/journal.pone.0079409 (2013).","journal-title":"PLoS One"},{"issue":"1","key":"16125_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2013.06.027","volume":"340","author":"H Tang","year":"2013","unstructured":"Tang, H. et al. Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22. Cancer Lett. 340(1), 72\u201381. https:\/\/doi.org\/10.1016\/j.canlet.2013.06.027 (2013).","journal-title":"Cancer Lett."},{"key":"16125_CR27","doi-asserted-by":"publisher","unstructured":"Shen, D. W. et al. MicroRNA-543 promotes cell invasion and impedes apoptosis in pituitary adenoma via activating the Wnt\/\u03b2-catenin pathway by negative regulation of Smad7. Biosci. Biotechnol. Biochem.  83(6), 1035\u20131044. https:\/\/doi.org\/10.1080\/09168451.2019.1591260 (2019).","DOI":"10.1080\/09168451.2019.1591260"},{"issue":"2","key":"16125_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00432-019-03114-8","volume":"146","author":"M Kasoha","year":"2020","unstructured":"Kasoha, M. et al. Crosstalk of Estrogen receptors and Wnt\/\u03b2-catenin signaling in endometrial cancer. J. Cancer Res. Clin. Oncol. 146(2), 315\u2013327. https:\/\/doi.org\/10.1007\/s00432-019-03114-8 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"16125_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00404-014-3219-3","volume":"290","author":"L Bing","year":"2014","unstructured":"Bing, L., Hong, C., Li-Xin, S. & Wei, G. MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression. Archieves Gynecol. Obstet. 290(3), 533\u2013541. https:\/\/doi.org\/10.1007\/s00404-014-3219-3 (2014).","journal-title":"Archieves Gynecol. Obstet."},{"key":"16125_CR30","doi-asserted-by":"publisher","first-page":"5559102","DOI":"10.1155\/2021\/5559102","volume":"2021","author":"X Liu","year":"2021","unstructured":"Liu, X., Xu, Q., Chen, C. & Duan, H. miR-543 inhibits the occurrence and development of intrauterine adhesion by inhibiting the proliferation, migration, and invasion of endometrial cells. Biomed. Res. Int. 2021, 5559102. https:\/\/doi.org\/10.1155\/2021\/5559102 (2021).","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"16125_CR31","doi-asserted-by":"publisher","first-page":"e94167","DOI":"10.1371\/journal.pone.0094167","volume":"9","author":"LJ Lee","year":"2014","unstructured":"Lee, L. J. et al. The KRAS-variant and MiRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PLoS One. 9(4), e94167. https:\/\/doi.org\/10.1371\/journal.pone.0094167 (2014).","journal-title":"PLoS One"},{"issue":"6","key":"16125_CR32","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/carcin\/bgp094","volume":"30","author":"WP Tsang","year":"2009","unstructured":"Tsang, W. P. & Kwok, T. T. The miR-18a* MicroRNA functions as a potential tumor suppressor by targeting on KRAS. Carcinogenesis 30(6), 953\u2013959. https:\/\/doi.org\/10.1093\/carcin\/bgp094 (2009).","journal-title":"Carcinogenesis"},{"issue":"1","key":"16125_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.18632\/oncotarget.1427","volume":"5","author":"F Kopp","year":"2014","unstructured":"Kopp, F., Wagner, E. & Roidl, A. The proto-oncogene KRAS is targeted by miR-200c. Oncotarget 5(1), 185\u2013195. https:\/\/doi.org\/10.18632\/oncotarget.1427 (2014).","journal-title":"Oncotarget"},{"issue":"19","key":"16125_CR34","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1038\/onc.2013.204","volume":"33","author":"M Tanaka","year":"2014","unstructured":"Tanaka, M. et al. EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis. Oncogene 33(19), 2454\u20132463. https:\/\/doi.org\/10.1038\/onc.2013.204 (2014).","journal-title":"Oncogene"},{"issue":"4","key":"16125_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/path.4309","volume":"232","author":"WT Liao","year":"2014","unstructured":"Liao, W. T. et al. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. J. Pathol. 232(4), 415\u2013427. https:\/\/doi.org\/10.1002\/path.4309 (2014).","journal-title":"J. Pathol."},{"issue":"6","key":"16125_CR36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00204-015-1474-0","volume":"89","author":"H Yamamoto","year":"2015","unstructured":"Yamamoto, H. & Imai, K. Microsatellite instability: an update. Arch. Toxicol. 89(6), 899\u2013921. https:\/\/doi.org\/10.1007\/s00204-015-1474-0 (2015).","journal-title":"Arch. Toxicol."},{"issue":"2","key":"16125_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/cbm-210353","volume":"34","author":"T Calvo-L\u00f3pez","year":"2022","unstructured":"Calvo-L\u00f3pez, T. et al. Association of miR-21 and miR-335 to microsatellite instability and prognosis in stage III colorectal cancer. Cancer Biomarkers. 34(2), 201\u2013210. https:\/\/doi.org\/10.3233\/cbm-210353 (2022).","journal-title":"Cancer Biomarkers"},{"key":"16125_CR38","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.3390\/ijms20236011","volume":"20","author":"E Hermyt","year":"2019","unstructured":"Hermyt, E. et al. Interplay between MiRNAs and genes associated with cell proliferation in endometrial cancer. Int. J. Mol. Sci. 20, 6011. https:\/\/doi.org\/10.3390\/ijms20236011 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"16125_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.21037\/atm.2020.03.54","volume":"8","author":"X Qu","year":"2020","unstructured":"Qu, X., Zhao, L., Zhang, R., Wei, Q. & Wang, M. Differential MicroRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma. Annals Translational Med. 8(7), 484. https:\/\/doi.org\/10.21037\/atm.2020.03.54 (2020).","journal-title":"Annals Translational Med."},{"issue":"4","key":"16125_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2353\/jmoldx.2010.090154","volume":"12","author":"JS Earle","year":"2010","unstructured":"Earle, J. S. et al. Association of MicroRNA expression with microsatellite instability status in colorectal adenocarcinoma. J. Mol. Diagn. 12(4), 433\u2013440. https:\/\/doi.org\/10.2353\/jmoldx.2010.090154 (2010).","journal-title":"J. Mol. Diagn."},{"issue":"2","key":"16125_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ygyno.2014.02.009","volume":"133","author":"YW Huang","year":"2014","unstructured":"Huang, Y. W. et al. Hypermethylation of miR-203 in endometrial carcinomas. Gynecol. Oncol. 133(2), 340\u2013345. https:\/\/doi.org\/10.1016\/j.ygyno.2014.02.009 (2014).","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"16125_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10147-013-0526-9","volume":"18","author":"K Banno","year":"2013","unstructured":"Banno, K. et al. MicroRNAs in endometrial cancer. Int. J. Clin. Oncol. 18(2), 186\u2013192. https:\/\/doi.org\/10.1007\/s10147-013-0526-9 (2013).","journal-title":"Int. J. Clin. Oncol."},{"issue":"2","key":"16125_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ygyno.2008.03.023","volume":"110","author":"T Boren","year":"2008","unstructured":"Boren, T. et al. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol. Oncol. 110(2), 206\u2013215. https:\/\/doi.org\/10.1016\/j.ygyno.2008.03.023 (2008).","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"16125_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3892\/or.2011.1574","volume":"27","author":"H Zhou","year":"2012","unstructured":"Zhou, H. et al. microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1. Oncol. Rep. 27(3), 807\u2013812. https:\/\/doi.org\/10.3892\/or.2011.1574 (2012).","journal-title":"Oncol. Rep."},{"issue":"3","key":"16125_CR45","doi-asserted-by":"publisher","first-page":"e90810","DOI":"10.1371\/journal.pone.0090810","volume":"9","author":"X Kong","year":"2014","unstructured":"Kong, X. et al. Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One. 9(3), e90810. https:\/\/doi.org\/10.1371\/journal.pone.0090810 (2014).","journal-title":"PLoS One"},{"issue":"15","key":"16125_CR46","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.18632\/oncotarget.2157","volume":"5","author":"Y Konno","year":"2014","unstructured":"Konno, Y. et al. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget 5(15), 6049\u20136062. https:\/\/doi.org\/10.18632\/oncotarget.2157 (2014).","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"16125_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11010-018-3313-0","volume":"448","author":"Y Liu","year":"2018","unstructured":"Liu, Y., Li, H., Zhao, C. & Jia, H. MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma. Mol. Cell. Biochem. 448(1\u20132), 61\u201369. https:\/\/doi.org\/10.1007\/s11010-018-3313-0 (2018).","journal-title":"Mol. Cell. Biochem."},{"key":"16125_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1478-811X-12-30","volume":"12","author":"J Banzhaf-Strathmann","year":"2014","unstructured":"Banzhaf-Strathmann, J. & Edbauer, D. Good guy or bad guy: the opposing roles of MicroRNA 125b in cancer. Cell. Communication Signal. 12, 30. https:\/\/doi.org\/10.1186\/1478-811X-12-30 (2014).","journal-title":"Cell. Communication Signal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16125-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16125-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16125-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:02:30Z","timestamp":1760140950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16125-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16125"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16125-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study approved by the Ethics Committee of Gazi University Hospital and appropriate informed consent was obtained from each patient (Decision date: 22th February, 2021, Decision number: 195).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"34697"}}